Purpose: To investigate the association between the N-acetyltransferase 1 (NAT1) slow and rapid acetylation phenotypes with cancer risk based on a meta-analysis.
Methods: Previously published case-control studies were retrieved from PubMed, Embase, and Web of Science. Odds ratios (ORs) with 95% confidence intervals (CIs) were determined to assess the relationship between NAT1 polymorphisms and cancer risk.
Results: A total of 73 studies (24874 cases and 30226 controls) were included in this meta-analysis. No significant association was identified between NAT1 polymorphisms (slow acetylation versus rapid acetylation genotypes: OR = 0.978, 95% CI = 0.927-1.030, P < 0.001 for heterogeneity, I(2) = 45.5%) and cancer risk, whereas a significantly reduced risk of pancreatic cancer was identified in individuals with NAT1 slow acetylation genotype (OR = 0.856, 95% CI = 0.733-0.999, P =0.509 for heterogeneity, I(2) = 0). When the NAT1 slow acetylation genotype was analysed on the basis of stratified analyses of ethnicity, a significantly reduced risk of head and neck cancers was found among Asian (OR=0.281, 95% CI = 0.127-0.622). When the NAT1 slow acetylation genotype was analysed on the basis of stratified analyses of source of control, only significantly reduced risks of colorectal cancer (OR = 0.882, 95% CI = 0.798- 0.974, P = 0.212 for heterogeneity, I(2) = 22.9) and pancreatic cancer (OR=0.856, 95% CI = 0.733-0.999, P = 0.509 for heterogeneity, I(2) = 0) were found among hospital-based studies.
Conclusions: No significant association between the NAT1 polymorphisms and the risk of cancer was found except for pancreatic cancer.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4537954 | PMC |
Publication Analysis
Top Keywords
Similar Publications
Differential expression of NAT1 pharmacogene in hormone receptor positive vs. negative female breast tumors may affect drug treatment.
Pharmacogenet Genomics
September 2024
Department of Molecular Biology and Genetics, Democritus University of Thrace, Alexandroupolis, Greece.
Studies have reported overexpression of NAT1 gene for xenobiotic metabolizing arylamine N -acetyltransferase type 1 in estrogen receptor positive breast tumors, and this association has been linked to patient chemoresistance and response to tamoxifen. We probed the expression of NAT1 , using quantitative reverse transcription PCR to screen clinically characterized breast cancer tissue cDNA arrays. Primers detecting all NAT1 alternative transcripts were used, and the protocol and results are reported according to consensus guidelines.
View Article and Find Full Text PDFModifying Effects of Genetic Variations on the Association Between Dietary Isothiocyanate Exposure and Non-muscle Invasive Bladder Cancer Prognosis in the Be-Well Study.
Mol Nutr Food Res
April 2024
Department of Cancer Prevention and Control, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA.
Article Synopsis
- Dietary isothiocyanates (ITCs) from cruciferous vegetables could positively impact the prognosis of non-muscle invasive bladder cancer (NMIBC) by possibly reducing progression risk, especially in individuals with certain genetic variations.
- The study analyzed data from 1,472 NMIBC patients, assessing their dietary intake of cruciferous vegetables and measuring ITC levels in their blood, using advanced statistical methods to determine the relationship between these factors and cancer outcomes based on specific gene variants.
- Results showed that while some genetic variations did affect the relationship between dietary ITCs and progression risk, a high intake of cruciferous vegetables was associated with a significant reduction in progression risk for most participants, suggesting dietary recommendations could enhance NMIBC survivorship.
Association of the cytochrome P450 and arylamine N-acetyltransferase gene polymorphisms with the incidence of head and neck cancer in Polish population.
Int J Occup Med Environ Health
December 2023
Medical University of Lodz, Łódź, Poland (Department of Clinical Chemistry and Biochemistry).
Objectives: Head and neck cancer (HNC) is one of the most common cancers. Most exogenous HNC is head and neck squamous cell carcinomas. Scientists are striving to develop diagnostic tests that will allow the prognosis of HNC.
View Article and Find Full Text PDFEffects of dose and human N-acetyltransferase 1 genetic polymorphism in benzidine metabolism and genotoxicity.
Arch Toxicol
June 2023
Department of Pharmacology and Toxicology and Brown Cancer Center, University of Louisville, School of Medicine, Louisville, KY, 40202, USA.
Benzidine undergoes N-acetylation and following CYP1A2-catalyzed N-hydroxylation undergoes O-acetylation catalyzed by N-acetyltransferase 1 (NAT1). Benzidine exposure is associated with urinary bladder cancer but the effect of NAT1 genetic polymorphism on individual risk remains unclear. We used Chinese hamster ovary (CHO) cells transfected with human CYP1A2 and NAT1*4 allele (reference) or NAT1*14B (variant) to investigate the effects of dose and NAT1 polymorphism on benzidine metabolism and genotoxicity.
View Article and Find Full Text PDFThe Role of Single-Nucleotide Polymorphisms in Cholangiocarcinoma: A Systematic Review.
Cancers (Basel)
December 2022
Department of Surgery and Transplantation, University Hospital RWTH Aachen, 52074 Aachen, Germany.
Single-nucleotide polymorphisms (SNPs) play an essential role in various malignancies, but their role in cholangiocarcinoma (CCA) remains to be elucidated. Therefore, the purpose of this systematic review was to evaluate the association between SNPs and CCA, focusing on tumorigenesis and prognosis. A systematic literature search was carried out using PubMed, Embase, Web of Science and the Cochrane database for the association between SNPs and CCA, including literature published between January 2000 and April 2022.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!